Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

BACKGROUND: Most SARS-CoV-2 infected patients develop IgG antibodies within 2–3 weeks after symptom onset. Antibody levels have been shown to gradually decrease in the first months after infection, but few data are available at six months or later. METHODS: A retrospective multi-center study was per...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Elslande, Jan, Oyaert, Matthijs, Ailliet, Scott, Van Ranst, Marc, Lorent, Natalie, Vande Weygaerde, Yannick, André, Emmanuel, Lagrou, Katrien, Vandendriessche, Stien, Vermeersch, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891078/
https://www.ncbi.nlm.nih.gov/pubmed/33636554
http://dx.doi.org/10.1016/j.jcv.2021.104765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891078/
https://www.ncbi.nlm.nih.gov/pubmed/33636554
http://dx.doi.org/10.1016/j.jcv.2021.104765

Ejemplares similares